Skip To Main Content

Investors & Media

Company Overview
View All

LyGenesis’s cell therapies are engrafted using endoscopic ultrasound procedure, which is associated with decreased medical risks and costs relative to full organ transplantation. Our pipeline of therapies target a variety of unmet needs, including end stage liver disease, Type 1 diabetes, end stage renal disease, aging, and autoimmune disorder.

LyGenesis Adds Inborn Metabolism Errors To Drug Pipeline

November 16, 2021 - LyGenesis adds orphan paediatric indications with large unmet needs to its drug development pipeline with novel approach which first aims to treat paediatric patients with Maple syrup urine disease.
Read More
Man holding a laughing baby up in the air

Lygenesis Featured In Pittsburgh Region Video

July 26, 2021 - Lygenesis is pioneering organ regeneration in Pittsburgh
Read More
Man in white lab coat and mask

The Incrementalist Interview

July 23, 2021 - Listen in to hear Michael share the exciting progress to data that has taken the human bio-reactor of lymph nodes, something that is hijacked for use by cancer cells and instead use it for good to generate liver, and in the future, pancreas, thymus and kidney. Delivering multiple organ transplants to many people from a single donor organ through an outpatient minor procedure.
Read More
Screenshot of podcast play button

Will You Live To 200? Five Levels of Breakthroughs in Longevity Research You Must Know About

May 6, 2021
Read More
stock photo of woman sitting cross-legged on a floor, smiling

Lygenesis' FDA Phase 2A Clearance and $11M Funding Boost

January 4, 2021 - Double bubble for biotech LyGenesis as it announces trial of its cell therapy for patients with end-stage liver disease, and closure of $11m convertible debt financing
Read More

Fox News: Liver Grown In Pigs' Lymph Nodes May Help Liver Disease Treatment: Study

September 22, 2020 - A liver grown in the lymph nodes of a pig could bring hope to patients dealing with liver disease, according to a new study. Researchers out of the University of Pittsburgh School of Medicine showed that pigs with damaged livers were able to use their own hepatocytes - a type of liver cell that functions as a natural regenerator, to grow a new organ in their lymph nodes, according to the study in journal Liver Transplantation.
Read More